Alvircept sudotox

Drug Profile

Alvircept sudotox

Alternative Names: CD4 PE; CD4 PE40; CD4 pseudomonas exotoxin; CD4(178) PE40; sCD4 PE40; U 85855

Latest Information Update: 27 May 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Pharmacia Corporation
  • Class Antineoplastics; Antivirals; Immunotoxins
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 05 Apr 2000 Discontinued - Phase II for HIV infections treatment in USA (unspecified route)
  • 08 Nov 1994 A clinical study has been added to the therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top